Larvol Delta - Circle-Pharma-Announces-First-Patients-Dosed-in-Phase-1-Clinical-Trial-of-FirstinClass-Oral-Cyclin-AB-RxL-Inhibitor-CID078-for-Advanced-Solid-Tumors

CID-078 - Circle Pharma

https://www.businesswire.com/news/home/20241015707785/en/Circle-Pharma-Announces-First-Patients-Dosed-in-Phase-1-Clinical-Trial-of-First-in-Class-Oral-Cyclin-AB-RxL-Inhibitor-CID-078-for-Advanced-Solid-Tumors

Oct 15, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next